Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionGreat Lakes Advisors, Llc
Latest Disclosed Ownership13,839 shares
Latest Disclosed Value $ 1,108,227
Great Lakes Advisors, Llc reports 7.48% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 11, 2026 - Great Lakes Advisors, Llc filed a 13F-HR form disclosing ownership of 13,839 shares of Edwards Lifesciences Corporation (MX:EW) valued at $1,108,227 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 14,958 shares of Edwards Lifesciences Corporation. This represents a change in shares of -7.48% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Edwards Lifesciences COM 28176E108 13,839 -1,119 -7.48 1,108 -13.10 0.0092
2026-02-12 2025-12-31 13F Edwards Lifesciences COM 28176E108 14,958 347 2.37 1,275 12.24 0.0104
2025-11-03 2025-09-30 13F Edwards Lifesciences COM 28176E108 14,611 321 2.25 1,136 1.70 0.0095
2025-08-11 2025-06-30 13F Edwards Lifesciences COM 28176E108 14,290 14,290 1,118 0.0094
2025-02-10 2024-12-31 13F Edwards Lifesciences COM 28176E108 0 -5,085 -100.00 0 -100.00
2024-11-04 2024-09-30 13F Edwards Lifesciences COM 28176E108 5,085 -273 -5.10 336 -32.19 0.0028
2024-08-06 2024-06-30 13F Edwards Lifesciences COM 28176E108 5,358 -2,972 -35.68 495 -37.94 0.0044
2024-05-08 2024-03-31 13F Edwards Lifesciences COM 28176E108 8,330 -5,820 -41.13 796 -26.16 0.0068
2024-02-08 2023-12-31 13F Edwards Lifesciences COM 28176E108 14,150 611 4.51 1,079 15.05 0.0103
2023-11-07 2023-09-30 13F Edwards Lifesciences COM 28176E108 13,539 -26,600 -66.27 938 -75.25 0.0085
2023-08-10 2023-06-30 13F Edwards Lifesciences COM 28176E108 40,139 7,341 22.38 3,786 39.55 0.0378
2023-05-10 2023-03-31 13F Edwards Lifesciences COM 28176E108 32,798 -1,381 -4.04 2,713 6.39 0.0247
2023-02-09 2022-12-31 13F Edwards Lifesciences COM 28176E108 34,179 -283 -0.82 2,550 -10.46 0.1461
2022-11-09 2022-09-30 13F Edwards Lifesciences COM 28176E108 34,462 -4,125 -10.69 2,848 -22.38 0.0622
2022-08-09 2022-06-30 13F Edwards Lifesciences COM 28176E108 38,587 -3,019 -7.26 3,669 -25.09 0.0725
2022-05-06 2022-03-31 13F Edwards Lifesciences COM 28176E108 41,606 -2,571 -5.82 4,898 -14.42 0.0626
2022-02-09 2021-12-31 13F Edwards Lifesciences COM 28176E108 44,177 -47,604 -51.87 5,723 -44.92 0.0871
2021-11-09 2021-09-30 13F Edwards Lifesciences COM 28176E108 91,781 27,494 42.77 10,391 56.07 0.1620
2021-08-11 2021-06-30 13F Edwards Lifesciences COM 28176E108 64,287 22,064 52.26 6,658 88.51 0.1004
2021-05-03 2021-03-31 13F Edwards Lifesciences COM 28176E108 42,223 -1,405 -3.22 3,532 -11.26 0.0571
2021-02-09 2020-12-31 13F Edwards Lifesciences COM 28176E108 43,628 1,739 4.15 3,980 19.02 0.0720
2020-11-04 2020-09-30 13F Edwards Lifesciences COM 28176E108 41,889 -770 -1.81 3,344 13.43 0.0708
2020-08-07 2020-06-30 13F Edwards Lifesciences COM 28176E108 42,659 28,892 209.86 2,948 13.52 0.0715
2020-05-08 2020-03-31 13F Edwards Lifesciences COM 28176E108 13,767 1,522 12.43 2,597 -9.10 0.0758
2020-02-07 2019-12-31 13F Edwards Lifesciences COM 28176E108 12,245 -1,508 -10.96 2,857 -5.52 0.0613
2019-11-06 2019-09-30 13F Edwards Lifesciences COM 28176E108 13,753 387 2.90 3,024 22.48 0.0664
2019-08-05 2019-06-30 13F Edwards Lifesciences COM 28176E108 13,366 -290 -2.12 2,469 -5.51 0.0538
2019-05-07 2019-03-31 13F Edwards Lifesciences COM 28176E108 13,656 -2,663 -16.32 2,613 4.52 0.0581
2019-02-13 2018-12-31 13F Edwards Lifesciences COM 28176E108 16,319 -21,110 -56.40 2,500 -61.63 0.0592
2018-11-30 2018-09-30 13F/A-2 Edwards Lifesciences COM 28176E108 37,429 -6,000 -13.82 6,516 3.07 0.1438
2018-11-15 2018-09-30 13F/A-1 EDWARDS LIFESCIENCE COM 28176E108 1,660 -35,769 289 0.0471
2018-11-14 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 43,429 0 6,322
2018-08-13 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 43,429 14,688 51.10 6,322 57.66 0.1482
2018-05-07 2018-03-31 13F EDWARDS LIFESCIENCES CS 28176E108 28,741 12,475 76.69 4,010 118.77 0.0955
2018-02-07 2017-12-31 13F EDWARDS LIFESCIENCES CS 28176E108 16,266 -4,593 -22.02 1,833 -19.61 0.0403
2017-11-13 2017-09-30 13F EDWARDS LIFESCIENCES CS 28176E108 20,859 20,859 2,280 0.0536
2016-11-07 2016-09-30 13F EDWARDS LIFESCIENCES CS 28176E108 0 -7,480 -100.00 0 -100.00
2016-08-12 2016-06-30 13F EDWARDS LIFESCIENCES CS 28176E108 7,480 -340 -4.35 746 8.12 0.0203
2016-05-11 2016-03-31 13F EDWARDS LIFESCIENCES CS 28176E108 7,820 1,699 27.76 690 42.86 0.0189
2016-02-12 2015-12-31 13F EDWARDS LIFESCIENCES CS 28176E108 6,121 6,121 0.00 483 0.0145
2015-02-11 2014-12-31 13F EDWARDS LIFESCIENCES CS 28176E108 0 -4,322 -100.00 0 -100.00
2014-11-20 2014-09-30 13F EDWARDS LIFESCIENCES CS 28176E108 4,322 4,322 441 0.0148
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.